<p>Rizatriptan Benzoate is contraindicated in patients with:</p>

<ul>
	<li>Ischemic&nbsp;coronary artery disease&nbsp;(angina pectoris, history of&nbsp;myocardial infarction, or documented silent ischemia), or other significant underlying&nbsp;cardiovascular disease</li>
	<li>Coronary artery vasospasm including Prinzmetal&#39;s&nbsp;angina</li>
	<li>History of&nbsp;stroke&nbsp;or&nbsp;transient ischemic attack&nbsp;(TIA)&nbsp;</li>
	<li>Peripheral vascular disease&nbsp;(PVD)&nbsp;</li>
	<li>Ischemic bowel disease&nbsp;</li>
	<li>Uncontrolled hypertension&nbsp;</li>
	<li>Recent use (i.e., within 24 hours) of another 5-HT1&nbsp;agonist, ergotamine-containing medication, or&nbsp;ergot-type medication (such as dihydroergotamine or methysergide)&nbsp;</li>
	<li>Hemiplegic&nbsp;or&nbsp;basilar&nbsp;migraine</li>
	<li>Concurrent administration or recent discontinuation (i.e., within 2 weeks) of a MAO-A inhibitor</li>
	<li>Hypersensitivity to Rizatriptan Benzoate (angioedema and&nbsp;anaphylaxisseen)</li>
</ul>